Notably, resistance to cisplatin has been reported to be associated with the induction of Akt expression in colon cancer [34], and Akt/mTOR pathway inhibition reduced cisplatin resistance in ovarian and lung cancer cells [35,36]. The gene discussed is AKT1; the disease is malignant colon neoplasm.